Skip to main content
. 2019 Dec 19;21(1):38. doi: 10.3390/ijms21010038

Figure 7.

Figure 7

No significant changes in K2P5.1 expression by the pharmacological inhibition of sirtuin-1 (SIRT1) in the splenic CD4+ T cells of IBD model mice and the T-cell lineage. (A–C) Real-time PCR assay for K2P5.1 in the splenic CD4+ T cells of IBD model mice (A), stimulated thymocytes (B), and mCTLL-2 cells (C), all of which were treated with a vehicle, vorinostat (1 µM), and NCO-01 (50 µM) for 24 h [n = 4 mice (A,B) and n = 4 batches (C)]. Expression levels are shown as a ratio to ACTB. Results are expressed as means ± SEM. **: p < 0.01 vs. vehicle control.